Overview

Cerebral Perfusion Pressure Using Precedex and Other Sedatives

Status:
Completed
Trial end date:
2013-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to examine the effects of using dexmedetomidine (Precedex) in addition to the current standard-of-care for sedation.
Phase:
Phase 3
Details
Lead Sponsor:
Duke University
Collaborators:
Hospira, Inc.
Hospira, now a wholly owned subsidiary of Pfizer
Treatments:
Dexmedetomidine
Hypnotics and Sedatives